Skip to main content

Werewolf joins pack of newly public biotechs with upsized $120M IPO

Listen for the howl: Cambridge oncology startup Werewolf Therapeutics has joined the public ranks, raising $120 million in an upsized initial public offering on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.